Status:
WITHDRAWN
N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life
Lead Sponsor:
Sheba Medical Center
Conditions:
Hypotension
Very Low Birth Weight Infants
Eligibility:
All Genders
1-3 years
Brief Summary
The primary objective is to test the hypothesis that there is an association between the hemodynamic status and the serum levels of NT-proBNP and cTnT in prematurely born infants. We would also evalua...
Detailed Description
NT-proBNP is a member of the natriuretic hormone family which plays an important role in regulation of extracellular fluid volume and blood pressure.It is secreted from the cardiac ventricle myocytes ...
Eligibility Criteria
Inclusion
- VLBW infants born at Sheba medical Center
Exclusion
- known cardiac or chromosomal anomaly
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00425581
Start Date
February 1 2007
Last Update
January 24 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.